Topicus.com Inc (TOI)
TSX Venture Exchange · Canada · prices in CAD · close of 22 Oct 2026
Key indicators
| Last close | CAD 98.19 |
|---|---|
| 52-week range | 82.67 – 160.89 |
| Return, 1 month / 3 months | +13.7% / +10.5% |
| Return, 1 year / 3 years | −31.5% / +15.9% |
| Trend | Uptrend |
| RSI (14) | 64 |
| Volatility (1 year) | 43.0% |
| Worst drawdown (1 year) | -46.0% |
| Average daily value traded | 8.26M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Topicus.com Inc is a software company based in the Netherlands that acquires and operates businesses making specialised software for specific industries. Its subsidiaries supply administrative and operational software to customers in sectors such as healthcare, education, local government and financial services, mainly across Europe. The company buys established software firms and lets them keep running their own products and serving their own markets, while providing central support for finance and acquisitions.
On this site Topicus.com Inc appears as a stock on the TSX Venture Exchange (Canada), code TOI, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Topicus.com Inc (TOI) trades on the TSX Venture Exchange in Canada. It last closed at CAD 98.19 on 22 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 168 of 1,501 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 31.5% and over the last three months it rose 10.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on TSX Venture Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.6% | ||
| From 52-week high | -36.7% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 10.5% | ||
| 6-month return | -5.6% | ||
| 12-month return, skipping the last month | -39.7% | ||
| Stability (higher is calmer) | 81 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -46.0% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 8.26M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +3.9% |
|---|---|
| 1 month | +13.7% |
| 3 months | +10.5% |
| 6 months | −5.6% |
| 1 year | −31.5% |
| 3 years | +15.9% |
| 5 years | −24.0% |
Signals
| 50-day / 200-day average | 94.69 / 97.60 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.66 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Mar 2024 | EUR 2.2710 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on TSX Venture Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.